InsiderTrades.com logo
Ori Gutwerg net worth and biography
  • Phone
  • Email
  • Website

Ori Gutwerg Biography and Net Worth

Senior Vice President, Generics of ANI Pharmaceuticals

Mr. Gutwerg is a seasoned leader and brings more than 17 years of experience building and driving growth in pharmaceutical companies. Most recently, Mr. Gutwerg served as Vice President, Head of U.S. Generics Rx at Taro Pharmaceuticals, overseeing a portfolio of nearly 300 generic and branded products. In that role, he drove double-digit top- and bottom-line growth, improved working capital through cost savings and efficiencies, rationalized the R&D pipeline and negotiated numerous business development deals to accelerate growth. Prior to joining Taro, he held positions with Xiromed US, Perrigo Pharmaceuticals, and Agis Group. Throughout his career, he has managed sales teams, built a commercial operations team, led M&A due diligence activities, and negotiated new business development and joint venture agreements. Mr. Gutwerg has a B.S. in Communications and Economics from The College of Management and an M.B.A. from Tel Aviv University.

What is Ori Gutwerg's net worth?

The estimated net worth of Ori Gutwerg is at least $5.22 million as of June 5th, 2024. Mr. Gutwerg owns 77,227 shares of ANI Pharmaceuticals stock worth more than $5,221,317 as of March 30th. This net worth evaluation does not reflect any other assets that Mr. Gutwerg may own. Additionally, Mr. Gutwerg receives an annual salary of $895,160.00 as Senior Vice President, Generics at ANI Pharmaceuticals. Learn More about Ori Gutwerg's net worth.

How old is Ori Gutwerg?

Mr. Gutwerg is currently 49 years old. There are 7 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Ori Gutwerg's age.

What is Ori Gutwerg's salary?

As the Senior Vice President, Generics of ANI Pharmaceuticals, Inc., Mr. Gutwerg earns $895,160.00 per year. There are 2 executives that earn more than Mr. Gutwerg. The highest earning executive at ANI Pharmaceuticals is Mr. Nikhil Lalwani, President, CEO & Director, who commands a salary of $2,320,000.00 per year. Learn More on Ori Gutwerg's salary.

How do I contact Ori Gutwerg?

The corporate mailing address for Mr. Gutwerg and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at ir@anipharmaceuticals.com. Learn More on Ori Gutwerg's contact information.

Has Ori Gutwerg been buying or selling shares of ANI Pharmaceuticals?

Ori Gutwerg has not been actively trading shares of ANI Pharmaceuticals during the past quarter. Most recently, Ori Gutwerg sold 2,985 shares of the business's stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $67.00, for a transaction totalling $199,995.00. Following the completion of the sale, the senior vice president now directly owns 77,227 shares of the company's stock, valued at $5,174,209. Learn More on Ori Gutwerg's trading history.

Who are ANI Pharmaceuticals' active insiders?

ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ANI Pharmaceuticals?

During the last year, insiders at the specialty pharmaceutical company sold shares 33 times. They sold a total of 268,126 shares worth more than $16,946,714.15. The most recent insider tranaction occured on March, 13th when VP Meredith Cook sold 400 shares worth more than $25,332.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.

Information on this page was last updated on 3/13/2025.

Ori Gutwerg Insider Trading History at ANI Pharmaceuticals

See Full Table

Ori Gutwerg Buying and Selling Activity at ANI Pharmaceuticals

This chart shows Ori Gutwerg's buying and selling at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500k$0$500kTotal Insider BuyingTotal Insider Selling

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More

Today's Range

Now: $67.61
Low: $67.02
High: $68.49

50 Day Range

MA: $60.49
Low: $54.51
High: $68.36

2 Week Range

Now: $67.61
Low: $52.50
High: $70.00

Volume

355,964 shs

Average Volume

256,304 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63